Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Unknown 3

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Conditions

Neoplasms 1905Breast Neoplasms 1426Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Breakthrough Cancer Pain × Clear all
NCT05531422 2024-06-12

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP

Lee's Pharmaceutical Limited

Phase 2 Completed
60 enrolled

Breakthrough Cancer Pain

NCT03895762 2022-05-05

OASIS

A.Menarini Asia-Pacific Holdings Pte Ltd

Completed
143 enrolled

Breakthrough Cancer Pain

NCT02899884 2019-11-22

Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain

Takeda

Completed
3,765 enrolled 10 charts

Breakthrough Cancer Pain

NCT01045603 2012-10-29

INIS

Takeda

Completed
309 enrolled

Breakthrough Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡